Avelox and Linzess drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Avelox (moxifloxacin hydrochloride) and Linzess (linaclotide). Common drug interactions include chronic kidney disease among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Avelox and Linzess. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Avelox?

Avelox has active ingredients of moxifloxacin hydrochloride. It is often used in sinusitis. eHealthMe is studying from 28,651 Avelox users. Check the latest studies of Avelox.

What is Linzess?

Linzess has active ingredients of linaclotide. It is often used in constipation. eHealthMe is studying from 24,086 Linzess users. Check the latest studies of Linzess.



On Jul, 18, 2026

17 people who take Avelox and Linzess together, and have interactions are studied.

Avelox and Linzess drug interactions.

What are the common drug interactions of Avelox and Linzess, by gender? *:

female:

  1. Chronic kidney disease
  2. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  3. Nephrogenic anaemia (anaemia due to kidney disease)
  4. Renal failure (kidney dysfunction)
  5. Abdominal pain
  6. Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)
  7. Acute left ventricular failure (heart attack)
  8. Acute respiratory failure
  9. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  10. Alopecia (absence of hair from areas of the body)

male:

  1. Anxiety
  2. Asthenia (weakness)
  3. Nikolsky's sign
  4. Rash
  5. Renal failure (kidney dysfunction)
  6. Respiratory disorder (respiratory disease)
  7. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  8. Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
  9. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  10. Conjunctival hyperaemia (congestion of conjunctival vessels)

What are the common drug interactions of Avelox and Linzess, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Anxiety
  4. Depression
  5. Gastric cancer (stomach cancer)
  6. Renal injury (kidney injury)

50-59:

  1. Chronic kidney disease
  2. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  3. Nephrogenic anaemia (anaemia due to kidney disease)
  4. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  5. Maculopathy (a condition or disease of the macula, the small spot in the retina where vision is keenest)
  6. Renal failure (kidney dysfunction)

60+:

  1. Alopecia (absence of hair from areas of the body)
  2. Asthenia (weakness)
  3. Nikolsky's sign
  4. Psychological trauma
  5. Rash
  6. Respiratory disorder (respiratory disease)
  7. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  8. Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
  9. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  10. Chronic kidney disease

What are the existing conditions these people have? *

  1. Infection: 13 people, 76.47%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 13 people, 76.47%
  3. Pain: 12 people, 70.59%
  4. High Blood Pressure: 11 people, 64.71%
  5. Irritable Bowel Syndrome: 9 people, 52.94%
  6. Nausea (feeling of having an urge to vomit): 9 people, 52.94%
  7. Fungal Infection: 9 people, 52.94%
  8. High Blood Cholesterol: 8 people, 47.06%
  9. Neuralgia (pain in one or more nerves): 8 people, 47.06%
  10. Cough: 8 people, 47.06%

* Approximation only. Some reports may have incomplete information.

Do you take Avelox and Linzess?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Avelox and Linzess:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Avelox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Linzess:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Avelox and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Linzess and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on moxifloxacin hydrochloride and linaclotide (the active ingredients of Avelox and Linzess, respectively), and Avelox and Linzess (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: